207 related articles for article (PubMed ID: 21752199)
1. Activity prediction of some nontested anticancer compounds using GA-based PLS regression models.
Nandi S; Bagchi MC
Chem Biol Drug Des; 2011 Oct; 78(4):587-95. PubMed ID: 21752199
[TBL] [Abstract][Full Text] [Related]
2. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: anticancer drug design by computed descriptors.
Nandi S; Bagchi MC
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):937-48. PubMed ID: 19555178
[TBL] [Abstract][Full Text] [Related]
3. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore identification and bioactivity prediction for triaminotriazine derivatives by electron conformational-genetic algorithm QSAR method.
Saripinar E; Geçen N; Sahin K; Yanmaz E
Eur J Med Chem; 2010 Sep; 45(9):4157-68. PubMed ID: 20598401
[TBL] [Abstract][Full Text] [Related]
5. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
[TBL] [Abstract][Full Text] [Related]
6. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
[TBL] [Abstract][Full Text] [Related]
8. Investigation of anticancer activity of macrocyclic Schiff bases by means of 4D-QSAR based on simplex representation of molecular structure.
Kuz'min VE; Artemenko AG; Lozytska RN; Fedtchouk AS; Lozitsky VP; Muratov EN; Mescheriakov AK
SAR QSAR Environ Res; 2005 Jun; 16(3):219-30. PubMed ID: 15804810
[TBL] [Abstract][Full Text] [Related]
9. The analysis of structure-anticancer and antiviral activity relationships for macrocyclic pyridinophanes and their analogues on the basis of 4D QSAR models (simplex representation of molecular structure).
Kuz'min VE; Artemenko AG; Lozitsky VP; Muratov EN; Fedtchouk AS; Dyachenko NS; Nosach LN; Gridina TL; Shitikova LI; Mudrik LM; Mescheriakov AK; Chelombitko VA; Zheltvay AI; Vanden Eynde JJ
Acta Biochim Pol; 2002; 49(1):157-68. PubMed ID: 12136936
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
12. Partial least squares modeling and genetic algorithm optimization in quantitative structure-activity relationships.
Hasegawa K; Funatsu K
SAR QSAR Environ Res; 2000; 11(3-4):189-209. PubMed ID: 10969871
[TBL] [Abstract][Full Text] [Related]
13. Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set.
Helguera AM; Rodríguez-Borges JE; García-Mera X; Fernández F; Cordeiro MN
J Med Chem; 2007 Apr; 50(7):1537-45. PubMed ID: 17341060
[TBL] [Abstract][Full Text] [Related]
14. Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM.
Deeb O; Goodarzi M
Chem Biol Drug Des; 2010 May; 75(5):506-14. PubMed ID: 20486937
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method.
Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):844-53. PubMed ID: 20429783
[TBL] [Abstract][Full Text] [Related]
16. Quantitative bioactivity prediction and pharmacophore identification for benzotriazine derivatives using the electron conformational-genetic algorithm in QSAR.
Sahin K; Sarıpınar E; Yanmaz E; Geçen N
SAR QSAR Environ Res; 2011 Jun; 22(3):217-38. PubMed ID: 21391137
[TBL] [Abstract][Full Text] [Related]
17. QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines with anticancer activity.
Atanasova M; Ilieva S; Galabov B
Eur J Med Chem; 2007 Sep; 42(9):1184-92. PubMed ID: 17408810
[TBL] [Abstract][Full Text] [Related]
18. A quantitative structure-activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors.
Basak SC; Mills D; Mumtaz MM
SAR QSAR Environ Res; 2007; 18(1-2):45-55. PubMed ID: 17365958
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners.
Naik PK; Alam A; Malhotra A; Rizvi O
J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251
[TBL] [Abstract][Full Text] [Related]
20. 3D and quantum QSAR of non-benzodiazepine compounds.
Pasha FA; Muddassar M; Cho SJ; Ahmad K; Beg Y
Eur J Med Chem; 2008 Nov; 43(11):2361-72. PubMed ID: 18346822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
